Mark Schiffman

Papers

Total Citations

H-Index

About

Mark Schiffman is a leading epidemiologist whose research has fundamentally shaped our understanding of cervical cancer causation and prevention. His key contributions center on the natural history of human papillomavirus (HPV) infection, establishing HPV as the necessary cause of cervical cancer and driving the development of HPV-based screening technologies. Schiffman’s landmark work with the NCI’s Costa Rica HPV Vaccine Trial and the Kaiser Permanente Northern California cohort provided definitive evidence for HPV testing’s superiority over cytology, leading to global screening guideline changes. His research on HPV genotyping and viral persistence has enabled risk stratification, allowing for safer extended screening intervals. With over 400 publications and more than 50,000 citations, Schiffman’s impact is immense. His studies on the stability of archived cytologic specimens, though less cited, underscore his meticulous attention to methodological rigor in large-scale biobanking. Schiffman’s work has been recognized with numerous awards, including the American Association for Cancer Research’s Team Science Award, and he continues to influence public health policy worldwide, making him a pivotal figure in the fight against cervical cancer.